Abstract
Germ-free immunocompetent (BALB/c) and immunodeficient (SCID) mice were colonized either byE. coli O6K 13 or byE. coli strain Nissle 1917 and intestinal inflammation was induced by administering 2.5 % dextran sulfate sodium (DSS) in drinking water. Controls were germ-free mice which demonstrated only mild inflammatory changes after induction of an acute intestinal inflammation with DSS as compared with conventional mice in which acute colitis of the colon mucosa similar to human ulcerative colitis is elicited. In mice monocolonized with the nonpathogenicE. coli Nissle 1917 the inflammatory disease did not develop (damage grade 0) while animals monocolonized with uropathogenicE. coli O6K 13 exhibited inflammatory changes similar to those elicited in conventionally reared mice (damage grade 3). In the chronic inflammation model, immunocompetent BALB/c mice monocolonized withE. coli Nissle 1917 showed no conspicuous inflammatory changes of the colon mucosa whereas those monocolonized withE. coli O6K 13 developed colon inflammation associated with marked infiltration of inflammatory cells. In contrast to germ-free immunodeficient SCID mice that died after application of DSS, the colon mucosa of SCID mice monoassociated withE. coli Nissle 1917 exhibited only moderate inflammatory changes which were less pronounced than changes of colon mucosa of SCID mice monoassociated withE. coli O6K 13.
Similar content being viewed by others
Abbreviations
- CFU:
-
colony forming units
- CV:
-
conventional(ly)
- DSS:
-
dextran sulfate sodium
- GF:
-
germ-free
- IBD:
-
inflammatory bowel disease
- IL-2:
-
interleukin-2
- INF-γ:
-
interferon γ
- SCID:
-
severe combined immunodeficiency
- UC:
-
ulcerative colitis
References
Altenhoefer A., Oswald S., Sonnenborn U., Enders C., Schulze J., Hacker J., Oelschlaeger T.A.: The probioticEscherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.Immunol.Med.Microbiol.9, 223–229 (2004).
Blum G., Marre R., Hacker J.: Properties ofEscherichia coli strains of serotype O6.Infection23, 234–236 (1995).
Bylund-Fellenius A.C., Lanström E., Axelsson L.G., Midtvedt T.: Experimental colitis induced by dextran sulfate in normal and germfree mice.Microb.Ecol.Health Dis.7, 207–215 (1994).
Cebra J.J.: Influences of microbiota on intestinal immune system development.Am.J.Clin.Nutr.69, 1046–1051 (1999).
Cooper H.S., Murthy S.N.S., Snak R.S., Sedergran D.S.: Clinicopathologic study of dextran sulfate sodium experimental murine colitis.U.S. & Canad.Acad.Pathol.69, 238 (1993).
Dahlgren U.I.H., Wold A.E., Hanson L.A., Mercereau-Puijalon O., Midtvedt T.: Expression of a dietary protein inEscherichia coli renders it strongly antigenic to gut lymphoid tissue.Immunology73, 394–397 (1991).
Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., Colombel J.F.: High prevalence of adherent-invasiveEscherichia coli associated with ileal mucosa in Crohn’s disease.Gastroenterology127, 412–421 (2004).
Dianda L., Hanby A.M., Wright N.A., Sebesteny A., Hayday A.C., Owen M.J.: T-Cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment.Am.J.Pathol.150, 91–97 (1997).
Dieleman Levinus A., Ridwan Ben U., Tennyson Gary S., Beagley Kenneth W., Bucy R.P., Elson C.O.: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.Gastroenterology107, 1643–1652 (1994).
Elson C.O., Cong Y., Kabal N.: Immuno-bacterial homeostasis in the gut: new insight into old enigma.Sem.Immunol.13, 187–194 (2001).
Farkas S., Herfarth H., Rössle M., Schroeder J., Steinbauer M., Guba A.M., Beham A., Schölmerich J., Jauch K.-W., Anthuber M.: Quantification of mucosal leukocyte endothelial cell interaction byin vivo fluorescence microscopy in experimental colitis in mice.Clin.Exp.Immunol.126, 250–258 (2001).
Faubion W.A., Sandborn W.J.: Probiotic therapy withE. coli for ulcerative colitis: the good with bad.Gastroenterology118, 630–631 (2001).
Fazzi P., Ciancaglini E., Soforza G.: Differential fluorescent staining method for detection of bacteria in blood cultures, cerebrospinal fluid and other clinical specimens.Eur.J.Clin.Microbiol.Infect.Dis.21, 373–378 (2002).
Folwaczny C.: Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?Gastroenterology38, 547–550 (2000).
García-Lafuente A., Antonin M., Guarner F., Crespo E., Salas A., Forcada P., Laguarda M., Cavaldá J., Baena J.A., Vilaseca J., Malagelada J.R.: Incrimination of anaerobic bacteria in the induction of experimental colitis.Am.J.Physiol.272, G10-G15 (1997).
Grozdanov L., Rasech C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Dobrindt U.: Analysis of the genome structure of the nonpathogenic probioticEscherichia coli Nissle 1917.J.Bacteriol.186, 5432–5441 (2004).
Hart A.L., Stagg A.J., Kamm A.J.: Related articles, links use of probiotics in the treatment of inflammatory bowel disease.J.Clin.Gastroenterol.36, 111–119 (2003).
Hudcovic T., Štěpánková R., Cebra J., Tlaskalová-Hogenová H.: The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice.Folia Microbiol.46, 565–572 (2001).
Hulten K., Almashhrawi A., El Zastari F.A.: Antibacterial therapy for Crohn’s disease: a review emphasizing therapy directed against mycobacteria.Dig.Dis.Sci.45, 445–456 (2000).
Kitajima S., Morimoto M., Sagara E., Shimizu C., Ikeda Z.: Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice.Exp.Anim.50, 387–395 (2001).
Kocourková I., Žádníková R., Žižka J., Rosová V.: Effect of oral application of a probioticE. coli strain on the intestinal microflora of children of allergic mothers during the first year of life.Folia Microbiol.52, 189–193 (2007).
Kokešová A., Frolová L., Kverka M., Sokol D., Rossmann P., Bártová J., Tlaskalová-Hogenová H.: Oral administration of probiotic bacteria (E. coli Nissle,E. coli O83,Lactobacillus casei) influences the severity of dextran-sodium-sulfate-induced colitis in BALB/c mice.Folia Microbiol.51, 478–484 (2006).
Kruis W., Frič P., Pokrotnieks J., Lukáš M., Fixa B., Kaščák M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., Schulze J.: Maintaining remission of ulcerative colitis with the probioticEscherichia coli Nissle 1917 is as effective as with standard mesalazine.Gut53, 1617–1623 (2004).
La Ferla K., Seegert D., Schreiber S.: Activation of NF-κB in intestinal byE. coli strain isolate from the colonic mucosa of IBD patients.Internat.J.Colorect.Dis.19, 334–342 (2004).
Mercereau-Puijalon O., Royal A., Cami B., Garapin A., Krust A., Gannon F., Kourilsky P.: Synthesis of an ovalbumin-like protein byEscherichia coli K-12 harboring a recombinant plasmid.Nature275, 505–510 (1978).
Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagi Y., Nakya R.: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.Gastroenterology98, 694–702 (1990).
Powrie F., Leach M.W.: Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.Ther.Immunol.2, 115–123 (1995).
Schuppler M., Lötzsch K., Waidmann M., Autenrieth I.B.: An abundance ofEscherichia coli is harbored by the mucosa associated bacterial flora of interleukin-2 deficient mice.Infect.Immun.72, 1983–1990 (2004).
Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., Rennick D.M., Sartor R.B.: Resident enteric bacteria are necessary in interleukin-10-deficient mice.Infect.Immun.66, 5224–5231 (1998).
Shanahan F.: Probiotics and inflammatory bowel disease: is there a scientific rationale?Inflamm.Bowel Dis.6, 107–115 (2000).
Štěpánková R.: Rearing of germ-free rats, mice, and rabbits, pp. 1537–1542 inImmunology Methods Manual (I. Lefkovits, Ed.),Gnotobiological Models (H. Tlaskalová, J. Šterzl, sect. Eds).Academic Press, New York 1997.
Swidsinski A., Landhoff A., Pernthaller A., Swidsinski S., Loening-Baucke V., Ordner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H.: Mucosal flora in inflammatory bowel disease.Gastroenterology122, 44–54 (2002).
Tlaskalová-Hogenová H., Štěpánková R., Hudcovic T., Tučková L., Cukrowska B., Lodinová-Žádníková R., Kozáková H., Rossmann P., Bártová J., Sokol D., Funda D.P., Borovská D., Řeháková Z., Šinkora J., Hofman J., Drastich P., Kokešová A.: Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.Immunol.Lett.93, 97–108 (2004).
Tlaskalová-Hogenová H., Tučková L., Štěpánková R., Hudcovic T., Palová-Jelínková L., Kozáková H., Rossmann P., Sanchez D., Cinová J., Hrnčíř T., Kverka M., Frolová L., Uhlig H., Powrie F., Bland P.: Involvement of innate immunity in the development of inflammatory and autoimmune diseases.Ann.N.Y.Acad.Sci.1051, 787–98 (2005).
Waidmann M., Bechtold O., Frick J., Lehr H., Schubert S., Dobrindt U., Loeffler J., Bohn E., Autenrieth I.B.:Bacteroides vulgatus protects againstEscherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.Gastroenterology125, 162–178 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants 303/04/0849 and 303/06/0974 ofCzech Science Foundation, by grant S500 200 572 of theAcademy of Sciences of the Czech Republic, byInstitutional Research Concept no. AV 0Z 5020 0510, and by grants 2B06 155 and 2B06 053 of theMinistry of Education, Youth and Sports of the Czech Republic.
Rights and permissions
About this article
Cite this article
Hudcovic, T., Štěpánková, R., Kozáková, H. et al. Effects of monocolonization withEscherichia coli strains O6K13 and nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice. Folia Microbiol 52, 618–626 (2007). https://doi.org/10.1007/BF02932191
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02932191